Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...

Discover why Nvidia Corporation's undervalued stock could soar, with analysts predicting strong earnings and YOY growth.

Wall Street is pulling further from its record after reports on Friday showed worries about President Donald Trump's policies may be hitting the U.S. economy.

Our fair value estimate for Inghams is AUD 3.70 per share. This implies a fiscal 2024 enterprise value/EBITDA of 4, a P/E ratio of 12, and fully franked dividend yield of 6%. Our DCF valuation assumes ...

File-sharing company Dropbox Inc. delivered fourth-quarter earnings and revenue that topped Wall Street’s estimates, but its ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

The toy company is looking to “diversify our manufacturing footprint to create optionality as we navigate the trade ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

Walmart on Thursday (Feb. 20) reported fiscal fourth quarter revenue of $180.55 billion, up 4.1% compared with the same ...

Growing NEV Adoption: The market for new market vehicles (NEVs) is on the rise in China. NIO expects vehicle deliveries in ...

Walmart stock fell more than 6.5% after the company delivered its fourth-quarter earnings report earlier Thursday. The stock ...